Last reviewed · How we verify
Tiotropium 2.5 µg b.i.d (tiotropium-2-5-g-b-i-d)
Tiotropium 2.5 µg b.i.d acts as an anticholinergic by blocking muscarinic receptors, leading to bronchodilation in the airways.
At a glance
| Generic name | tiotropium-2-5-g-b-i-d |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 2 |
Mechanism of action
Tiotropium 2.5 µg b.i.d works by blocking muscarinic receptors in the lungs, which helps relax the muscles around the airways and makes breathing easier. This effect is achieved through its action on the M3 receptor, a key player in airway smooth muscle contraction.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tiotropium 2.5 µg b.i.d CI brief — competitive landscape report
- Tiotropium 2.5 µg b.i.d updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI